Kane Biotech, Inc. (KNBIF)
0.0274
0.00 (0.00%)
USD |
OTCM |
Feb 23, 16:00
Kane Biotech EPS Diluted (Quarterly) : -0.0026 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hear AtLast Holdings, Inc. | -0.0003 |
| Pharmagreen Biotech, Inc. | 0.0001 |
| CeCors, Inc. | -- |
| Venus Concept, Inc. | -12.14 |
| Achieve Life Sciences, Inc. | -0.2831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.441M |
| Revenue (Quarterly) | 0.0062M |
| Total Expenses (Quarterly) | 0.4471M |
| Enterprise Value | 5.562M |
| Gross Profit Margin (Quarterly) | -483.9% |
| Profit Margin (Quarterly) | -7.11K% |
| Earnings Yield | -31.39% |
| Normalized Earnings Yield | -31.75 |